Vijaypd Ceutical
September 29, 2025 – October 1, 2025
| Price | ₹35 - ₹35 |
| GMP Rumors * | ₹0 |
|---|---|
| Lot size | 4000 |
| Allotment | Oct 3, 2025 |
| Listing | Oct 7, 2025 |
Vijaypd Ceutical Lot(s) Distribution
| Category | Lot(s) | Qty | Amount | Reserved |
|---|---|---|---|---|
| INDIVIDUAL | 2 | 8000 | 280000 | 326 |
| HNI | 3 | 12000 | 420000 | 217 |
Vijaypd Ceutical Reservation
| Category | Shares Offered | % |
|---|---|---|
| HNI | 2608000 | 47.42% |
| INDIVIDUAL | 2608000 | 47.42% |
| Market Maker | 284000 | 5.16% |
| Total | 5500000 | 100% |
Vijaypd Ceutical About
Vijaypd Ceutical IPO Details
| Total Issue Size | 55,00,000 shares (aggregating up to ₹19.25 Cr) |
| Fresh Issue | 55,00,000 shares (aggregating up to ₹19.25 Cr) |
| Issue Type | Fixed Price IPO |
| Listing At | NSE SME |
| Share Holding Pre Issue | 14,028,686 shares |
| Share Holding Post Issue | 19,528,686 shares |
| Reserved for Market Maker | 284,000 shares (aggregating up to ₹0.9940 Cr) |
| Market Maker | Shreni Shares Ltd. |
Key Performance Indicator (KPI)
| KPI | Mar-25 | Mar-24 | Mar-23 |
|---|---|---|---|
| ROE | 28.91% | 55.64% | 3.96% |
| ROCE | 17.30% | 14.61% | 8.90% |
| EPS (basic) | 3.84 | 8.25 | 0.91 |
Financial Details (In ₹Crores)
| Period Ended | Mar-25 | Mar-24 | Mar-23 |
|---|---|---|---|
| Assets | 57.15 | 33.27 | 32.87 |
| Total Income | 107.59 | 54.34 | 50.59 |
| Profit After Tax | 4.8 | 1.65 | 0.18 |
| EBITDA | 8.59 | 4.87 | 1.32 |
| NET Worth | 32.17 | 1 | 4.93 |
| Reserves and Surplus | 18.14 | - | - |
| Total Borrowing | 21.77 | 30.04 | 25.56 |
Peer Comparision (Valuation)
| Company | P/E (x) | CMP*(₹) | Face value (₹) |
|---|---|---|---|
| Vijaypd Ceutical Limited | - | - | 10.00 |
| MedPlus Health Services Limited | 249.42 | 840.55 | 2.00 |
| Entero Healthcare Solutions Limited | 256.17 | 1129.7 | 10.00 |
Peer Comparision (Financial Performance)
| Company | NAV/Share (₹) | RoNW (%) | EPS (Basic) (₹) |
|---|---|---|---|
| Vijaypd Ceutical Limited | 25.78 | 14.91% | 3.84 |
| MedPlus Health Services Limited | 103.63 | 3.32% | 3.37 |
| Entero Healthcare Solutions Limited | 379.33 | 1.17% | 4.41 |
About Company
Vijaypd Ceutical Limited, incorporated in October 1971, is a established distributor serving the pharmaceutical and consumer goods markets. The company acts as a multi-faceted supply chain partner, operating as a representative, dealer, agent, stockist, supplier, trader, and packer.
Core Business & Product Portfolio
The company caters to two primary sectors with an extensive range of products:
Pharmaceuticals & Wellness:
Medicines: Injections, tablets, capsules, ointments, suppositories, ophthalmic preparations, liquid orals.
Healthcare Products: Vitamins, hormones, enzymes, wellness tonics, serums, diagnostic test kits.
Ayurvedic medicines and crude drugs.
Fast-Moving Consumer Goods (FMCG):
Personal Care: Soaps, sanitizers, baby care products, cosmetics.
Other: Food items, dental products.
Market Reach & Distribution
Customer Base: Serves over 2,109 pharmacies, clinics, and nursing homes.
Geographical Coverage: Operates across 20 locations spanning four districts.
Supplier Network: Maintains a robust distribution network, connecting with over 170 healthcare product manufacturers.
Product Variety: Provides access to a vast portfolio of more than 19,000 Stock-Keeping Units (SKUs).
Certifications & Compliance
The company is a recognized pharmaceutical distributor holding certifications from:
FDA (Food and Drug Administration)
FSSAI (Food Safety and Standards Authority of India)
BMC (Brihanmumbai Municipal Corporation - likely for its premises)
The net proceeds of ₹16.67 Crores from Vijaypd Ceutical's IPO will be used for:
Building a new API manufacturing plant in Shrirampur, Maharashtra (₹10.83 Cr).
Repaying existing company debt (₹5.10 Cr).
General corporate purposes and working capital (₹0.74 Cr).
Strength
Strong client relationships – long-term partnerships help ensure stable business.
Comprehensive product portfolio – ability to serve diverse customer needs.
Efficient supply chain management – supports timely delivery and cost optimization.
Weakness
Expansion into APIs & Excipients – exposes the company to operational and financial risks.
Product development failure risk – potential regulatory hurdles or lack of market acceptance.
Dependence on limited customers/markets – could impact revenue and profitability in early stages.
Vijaypd Ceutical Lead Manager(s)
Vijaypd Ceutical Address
A/1, 1st Floor
Devraj Premises
CHSL, Goregaon West
Mumbai, Maharashtra, 400062
Phone: +91 9820917040
Email: investors@vijaypdceutical.com
Website: https://www.vijaypdceutical.com/
Vijaypd Ceutical Registrar
Vijaypd Ceutical Reviewers
| Reviewer | Recommendation | File |
|---|